跳至主要内容
临床试验/jRCT1080223307
jRCT1080223307招募中3 期

Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM- 001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease

Metcela Inc.1 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
Metcela Inc.
入组人数
40
试验地点
1
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
干预模型
Multicenter, Randomized, Standard-of-care Controlled, Single-blind, Parallel-group
主要目的
Treatment Purpose

入排标准

年龄范围
No limit 至 6age old under(—)
性别
All

入选标准

  • Main inclusion criteria:
  • Functional single ventricle patient who is scheduled for stage 2 (Glenn) or stage 3 (Fontan) surgery
  • Ejection fraction (%) by echocardiography =< 55%

排除标准

  • Main exclusion criteria:
  • Known medical history of cardiogenic shock
  • Lethal, uncontrollable arrhythmia
  • Complication of coronary artery disease
  • Eisenmenger syndrome
  • Complication of brain dysfunction due to circulatory failure
  • Malignant neoplasm
  • Complication of severe neurologic disorder
  • Severe pulmonary embolism or pulmonary hypertension
  • Severe renal failure
  • Multiple organ failure
  • Active infection (including endocarditis)
  • Active hemorrhagic disease (e.g. gastrointestinal bleeding, injury)

结局指标

主要结局

-

efficacy confirmatory Ejection fraction assessed by cardiac MRI

次要结局

  • Cardiac function

研究者

发起方
Metcela Inc.

研究点 (1)

Loading locations...

相似试验